Investment Summary

Credian Partners Invests In Macrogen

On February 11, 2016, private equity firm Credian Partners invested in life science company Macrogen

Investment Highlights
  • This is Credian Partners’ 1st transaction in the Life Science sector.
  • This is Credian Partners’ 1st transaction in South Korea.

Investment Summary

Date 2016-02-11
Target Macrogen
Sector Life Science
Investor(s) Credian Partners
Deal Type Growth Capital

Target

Macrogen

Seoul, South Korea
Macrogen has continued to be actively engaged in R&D fields for genetic and genomic analyses. In addition to providing services to clients around the world, Macrogen contributes to the advancement of bioindustries through a wide range of CSR activities. Macrogen was founded in 1997 and is based in Seoul, South Korea.

Search 205,615 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

DESCRIPTION

Credian Partners is a Korean private equity firm specializing in strategic acquisitions, corporate divestitures, recapitalizations and growth equity investments. The Firm is a generalist investor and typically seeks companies with stable cashflows and strong growth prospects, but Credian will also selectively consider financially distressed situations as well. Credian Partners was formed in 2014 and is headquartered in Seoul.


DEAL STATS #
Overall 1 of 2
Sector (Life Science) 1 of 1
Type (Growth Capital) 1 of 1
Country (South Korea) 1 of 1
Year (2016) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-04-06 NuScale Power

Portland, Oregon, United States

NuScale Power is a nuclear plant, a smaller, scalable version of pressurized water reactor technology, designed with natural safety features. NuScale Power was founded in 2007 and is based in Portland, Oregon.

Buy -